Skip to content
Screener

Cardinal Health CAH Return on equity

Discontinued — last reported Q2 '22

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
Alpha Pro Tech logo
Alpha Pro TechAPT
5.4%-0.8pp
Cencora logo
CencoraCOR
130.6%-99.8pp
AbbVie logo
AbbVieABBV
89%+32.7pp
AVN
AVNSAVNS
-9.2%-3.9pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-52.8%-12.7pp

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$53.87B+42.3%
Enterprise value$58.85B+35.2%
P/E34.7×+10.4×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Calculated from Cardinal Health’s reported figures.

net income/total stockholders equity=37.4%

Based on trailing twelve months.

The source filing: Cardinal Health’s 10-Q, filed February 2, 2023. Open the filing →

Filed
Feb 2, 2023
Fiscal quarter
Q3 FY2023
Calendar quarter
Q1 2023
Accession
0000721371-23-000007

FAQ

What is Cardinal Health's return on equity?
Cardinal Health (CAH) reported return on equity of 37.4% in Q4 2021.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Cardinal Health's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude